Gotham Asset Management, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,332,730
-10.2%
114,006
+3.2%
0.03%
-12.5%
Q2 2023$1,484,771
-35.8%
110,474
-20.8%
0.03%
-42.9%
Q1 2023$2,312,098
+552.7%
139,451
+632.2%
0.06%
+460.0%
Q4 2022$354,237
-45.0%
19,045
-62.0%
0.01%
-47.4%
Q3 2022$644,000
+563.9%
50,175
+53.7%
0.02%
+533.3%
Q3 2020$97,000
-70.0%
32,653
-53.3%
0.00%
-70.0%
Q2 2020$323,000
-33.9%
69,872
-45.0%
0.01%
-28.6%
Q1 2020$489,000
+256.9%
126,934
+247.6%
0.01%
+366.7%
Q4 2019$137,000
-35.1%
36,514
-8.3%
0.00%
-25.0%
Q3 2019$211,00039,8200.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders